Download image:

Jenny L. Wiley

Senior Fellow, Behavioral Pharmacology

Jenny Wiley, PhD, is a leading expert in behavioral pharmacology who has worked extensively with various multidisciplinary and multi-institutional teams focused on studies that use a wide range of methods from molecular to behavioral.

Dr. Wiley designs and supervises a program of in vivo research that complements existing strengths of the Center for Discovery and Analytical Sciences, including the synthesis and development of candidate medications and investigation of neural mechanisms underlying substance abuse. She also conducts independent National Institutes of Health grant-supported research in the area of cannabinoid pharmacology, an area in which she has an extensive record of peer-reviewed publications.

Before joining RTI in March 2010, Dr. Wiley was a professor in the Department of Pharmacology and Toxicology at VCU, where she still maintains an affiliate appointment. Additionally, she has been involved in governance of the International Cannabinoid Research Society for many years and served as the Society’s president at the 2013 meeting.


Postdoctoral Fellowship, Pharmacology, Virginia Commonwealth University; PhD, Biological Psychology, Virginia Commonwealth University; MS, Biological Psychology, Virginia Commonwealth University; BS, Psychology (minor: English), College of William and Mary.

Latest Publications

Marusich, J.A., Antonazzo, K.R., Wiley, J.L., Blough, B.E., Partilla, J.S., & Baumann, M.H. (2014). Pharmacology of novel synthetic stimulants structurally related to the 'bath salts' constituent 3,4-methylenedioxypyrovalerone (MDPV). Neuropharmacology, 87 :206-213.
Wiley, J.L., Marusich, J.A., Thomas, B.F., & Jackson, K.J. (2014). Determination of behaviorally effective tobacco constituent doses in rats. Nicotine and Tobacco Research, Advance Online Publication .
German, N., Decker, A.M., Gilmour, B.P., Gay, E.A., Wiley, J.L., Thomas, B.F., & Zhang, Y. (2014). Diarylureas as Allosteric Modulators of the Cannabinoid CB1 Receptor: Structure-Activity Relationship Studies on 1-(4-Chlorophenyl)-3-{3-[6-(pyrrolidin-1-yl)pyridin-2-yl]phenyl}urea (PSNCBAM-1). Journal of Medicinal Chemistry, 57 (18):7758-7769.
Wiley, J.L., Lefever, T.W., Cortes, R.A., & Marusich, J.A. (2014). Cross-Substitution of Delta9-Tetrahydrocannabinol and JWH-018 in Drug Discrimination in Rats. Pharmacology, Biochemistry, and Behavior, 124 :123-128.
Wakley, A.A., Wiley, J.L., & Craft, R.M. (2014). Sex differences in antinociceptive tolerance to delta-9-tetrahydrocannabinol in the rat. Drug and Alcohol Dependence, 143 :22-28.
View all publications by Jenny L. Wiley (162)


  • Cannabinoid Pharmacology
  • Behavioral Pharmacology
  • Neuropharmacology
  • Animal Models of Substance Abuse